Four simple, sensitive and selective stability indicating spectrophotometric methods are presented for quantitative determination of the benzodiazepine drug; bromazepam (BMZ) and one of its reported potential impurities and degradation product; 2-(2-amino-5-bromobenzoyl) pyridine (ABP) in methanol. Method A, is isoabsorptive point coupled with D0 method, where good linearity was obtained by measuring the absorbance of BMZ at 264nm (Aiso) in the concentration range of 2-25μgmL-1, and the absorbance of ABP at its λmax 396nm in concentration range of 0.5-24μgmL-1. Method B, is ratio subtraction; the absorbance was measured at 233nm for BMZ using 20μgmL-1 of ABP, while ABP was determined directly at its λmax 396nm using methanol as a solvent. Method C, was based on measuring the total peak amplitude of the first derivative of the ratio spectra (DD1) of BMZ from 301 to 326nm using 10μgmL-1 of ABP as a divisor and determination of ABP at peak amplitude of 293nm using 5μgmL-1 of BMZ as a divisor. In method D, ratio difference method, good linearity was achieved for determination of BMZ and ABP by measuring the differences between the amplitudes of ratio spectra at 312nm and 274nm and differences between the amplitudes of ratio spectra at 274nm and 312nm, respectively. The stability of BMZ was investigated under different ICH recommended forced degradation conditions. The suggested methods were then successfully applied for determination of BMZ in its pharmaceutical formulations.